Chao, T., Braunwald, E., Palazzolo, M. G., Antman, E. M., Carnicelli, A. P., Connolly, S. J., … Giugliano, R. P. (2024). Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF. In European Heart Journal (Vol. 45). Oxford University Press (OUP). https://doi.org/10.1093/eurheartj/ehae666.605

Chao, T., E. Braunwald, M. G. Palazzolo, E. M. Antman, A. P. Carnicelli, S. J. Connolly, J. Eikelboom, et al. “Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF.” In European Heart Journal, Vol. 45. Oxford University Press (OUP), 2024. https://doi.org/10.1093/eurheartj/ehae666.605.

Chao T, Braunwald E, Palazzolo MG, Antman EM, Carnicelli AP, Connolly SJ, et al. Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF. In: European Heart Journal. Oxford University Press (OUP); 2024.

Chao, T., et al. “Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF.” European Heart Journal, vol. 45, no. Supplement_1, Oxford University Press (OUP), 2024. Crossref, doi:10.1093/eurheartj/ehae666.605.

Chao T, Braunwald E, Palazzolo MG, Antman EM, Carnicelli AP, Connolly SJ, Eikelboom J, Granger CB, Patel MR, Ruff CT, Wallentin L, Giugliano RP. Clinical outcomes in >10,000 Asian vs >61,000 Non-Asian race patients with AF randomized to Warfarin vs DOACs: a patient-level meta-analyses from COMBINE AF. European Heart Journal. Oxford University Press (OUP); 2024.